According to Moderna 's latest financial reports the company's current revenue (TTM) is $22.60 B. In 2021 the company made a revenue of $18.47 B an increase over the years 2020 revenue that were of $0.80 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $22.60 B | 22.35% |
2021 | $18.47 B | 2199.12% |
2020 | $0.80 B | 1234.34% |
2019 | $0.06 B | -55.42% |
2018 | $0.13 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $94.88 B | 319.82% | ๐บ๐ธ USA |
![]() Novartis NVS | $51.74 B | 128.96% | ๐จ๐ญ Switzerland |
![]() Merck MRK | $53.97 B | 138.84% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | N/A | -100.00% | ๐บ๐ธ USA |
![]() Dicerna Pharmaceuticals DRNA | $0.19 B | -99.15% | ๐บ๐ธ USA |
![]() Athersys ATHX | $8.42 M | -99.96% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $0.87 B | -96.11% | ๐บ๐ธ USA |
![]() Arrowhead Pharmaceuticals
ARWR | $0.26 B | -98.83% | ๐บ๐ธ USA |